SelectQuote, Inc. Q4 2026 Earnings Call Summary

SelectQuote, Inc. unveiled its fourth-quarter 2026 earnings on a call with analysts, highlighting key growth drivers and strategic priorities. The company's Healthcare Services division emerged as the largest revenue contributor, contributing $50 million in annual EBITDA. The segment maintained durable profitability with 26% adjusted EBITDA margins, despite challenges in the Medicare Advantage market.

Operating cash flow improved by $44 million year-over-year, propelled by expanded scale at the Olathe, Kansas distribution center and a maturing SelectRx member base.

Efficiency gains through AI-enabled enrollment tools, automated revenue processes, and organizational right-sizing resulted in over $30 million in annualized expense reductions. The upcoming fiscal 2027 is viewed as a critical inflection point for equity value accretion, with the company prioritizing cash flow generation and leverage reduction.

Revenue is projected to decline 14% midway through fiscal 2027, driven by a 10% to 15% drop in Medicare Advantage approved policies and similar declines in Healthcare Services due to the Inflation Reduction Act.

Management anticipates operating cash flow to nearly double to $60 million or more in fiscal 2027, with free cash flow targeted at $50 million. Healthcare Services margins are expected to approximately double as more scripts route through the more efficient Kansas facility. The upcoming Annual Enrollment Period (AEP) is expected to return to responsible growth, with the probability of new receivable securitization low in the short term.

The company remains focused on de-leveraging and transitioning to cash payments on PIK interest, targeting high-ROI investments to lower the overall cost of capital.